Today's Low
₹
Today's High
₹
52 Weeks Low
₹ 294.70
52 Weeks High
₹ 440.40
Lower
₹ 670.90
Upper
₹ 819.90
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars |
---|
Total Current Assets |
Total Non-Current Assets |
Total Assets |
Total Current Liabilities |
Total Non-Current Liabilities |
Shareholder's Funds |
Total Liabilities |
The Industry Debt to Equity Ratio stands at 1.06, vs the Debt to Equity Ratio of 0.24, which results in a Positive aspect.
The Industry Quick Ratio stands at 0.63, vs the Quick Ratio of 0.39, which results in a Negative aspect.
The Industry Current Ratio stands at 1.82, vs the Current Ratio of 1.82, which results in a Positive aspect.
The Industry Price to BV stands at 6.57, vs the Price to BV of 5.66, which results in a Negative aspect.
Particulars |
---|
The Industry Dividend Yield stands at 0.27, vs the Dividend Yield of 0.55, which results in a Positive aspect.
The Industry PAT Growth stands at 111.70, vs the PAT Growth of -501.66, which results in a Negative aspect.
The Industry PAT Margin stands at 5.31, vs the PAT Margin of -24.32, which results in a Negative aspect.
The Industry PE Ratio stands at 76.08, vs the PE Ratio of 79.13, which results in a Positive aspect.
Particulars |
---|
Profit Before Tax |
Tax Paid |
Adjustment |
Changes In Working Capital |
Cash Flow after changes in Working Capital |
Cash Flow from Operating Activities |
Cash Flow from Investing Activities |
Cash Flow from Financing Activities |
Net Cash Inflow / Outflow |
Opening Cash & Cash Equivalents |
Closing Cash & Cash Equivalent |
The Industry PFCF Ratio stands at -62.13, vs the PFCF Ratio of -13.35, which results in a Positive aspect.
The Industry PCF RATIO stands at 7.18, vs the PCF RATIO of 95.69, which results in a Positive aspect.
Particulars | Dec 2024 | Sep 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 15,287.1 | 19,750.2 | 15,212.5 | 13,476.8 | 14,232.3 | 14,560.6 | 14,948.0 | 13,023.4 | 14,416.3 | 15,472.6 | 15,497.0 | 14,809.0 | 11,395.3 | 17,125.7 | 15,430.3 | 16,098.2 | 5,486.3 | 16,942.0 |
Total Income | 17,374.7 | 21,808.3 | 16,435.1 | 14,764.2 | 15,217.1 | 15,757.0 | 15,596.6 | 13,605.0 | 15,162.8 | 16,521.3 | 16,869.2 | 15,565.3 | 12,422.7 | 19,065.9 | 16,682.2 | 17,230.9 | 6,469.8 | 18,738.0 |
Total Expenditure | 11,287.2 | 14,729.8 | 10,102.8 | 8,853.3 | 10,270.6 | 10,577.1 | 10,176.0 | 8,656.7 | 10,279.7 | 11,797.2 | 10,283.8 | 10,226.4 | 7,440.9 | 12,587.1 | 10,439.5 | 11,467.0 | 5,469.0 | 13,775.1 |
PBIDT (Excl OI) | 3,999.9 | 5,020.4 | 5,109.7 | 4,623.5 | 3,961.7 | 3,983.5 | 4,772.0 | 4,366.7 | 4,136.6 | 3,675.4 | 5,213.2 | 4,582.6 | 3,954.4 | 4,538.6 | 4,990.8 | 4,631.2 | 17.3 | 3,166.9 |
Other Income | 2,087.6 | 2,058.1 | 1,222.6 | 1,287.4 | 984.8 | 1,196.4 | 648.6 | 581.6 | 746.5 | 1,048.7 | 1,372.2 | 756.3 | 1,027.4 | 1,940.2 | 1,251.9 | 1,132.7 | 983.5 | 1,796.0 |
Operating Profit | 6,087.5 | 7,078.5 | 6,332.3 | 5,910.9 | 4,946.5 | 5,179.9 | 5,420.6 | 4,948.3 | 4,883.1 | 4,724.1 | 6,585.4 | 5,338.9 | 4,981.8 | 6,478.8 | 6,242.7 | 5,763.9 | 1,000.8 | 4,962.9 |
Interest | 939.0 | 935.1 | 837.4 | 901.6 | 848.5 | 845.6 | 954.3 | 1,069.3 | 1,052.2 | 1,282.0 | 1,455.3 | 1,758.9 | 1,749.3 | 1,912.3 | 1,984.6 | 2,263.0 | 2,373.6 | 2,352.7 |
Exceptional Items | -3,023.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2,244.3 | 0.0 | 0.0 | 0.0 | 0.0 | -962.1 | 0.0 | -3,306.7 |
PBDT | 2,124.6 | 6,143.4 | 5,494.9 | 5,009.3 | 4,098.0 | 4,334.3 | 4,466.3 | 3,879.0 | 3,830.9 | 3,442.1 | 2,885.8 | 3,580.0 | 3,232.5 | 4,566.5 | 4,258.1 | 2,538.8 | -1,372.8 | -696.5 |
Depreciation | 387.4 | 377.3 | 379.5 | 369.6 | 363.6 | 360.4 | 385.9 | 366.7 | 373.3 | 369.1 | 373.5 | 372.6 | 379.2 | 385.0 | 390.5 | 397.3 | 422.0 | 600.7 |
Profit Before Tax | 1,737.2 | 5,766.1 | 5,115.4 | 4,639.7 | 3,734.4 | 3,973.9 | 4,080.4 | 3,512.3 | 3,457.6 | 3,073.0 | 2,512.3 | 3,207.4 | 2,853.3 | 4,181.5 | 3,867.6 | 2,141.5 | -1,794.8 | -1,297.2 |
Tax | -2,666.8 | -4,668.0 | 1,350.4 | 1,122.0 | 1,014.2 | 1,125.4 | 1,103.9 | 909.6 | 876.1 | 837.6 | 600.2 | 944.1 | 827.9 | 1,594.3 | 1,042.4 | 1,000.5 | -14.4 | 19,073.3 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 4,404.0 | 10,434.1 | 3,765.0 | 3,517.7 | 2,720.2 | 2,848.5 | 2,976.5 | 2,602.7 | 2,581.5 | 2,235.4 | 1,912.1 | 2,263.3 | 2,025.4 | 2,587.2 | 2,825.2 | 1,141.0 | -1,780.4 | -20,370.5 |
Net Profit | 4,404.0 | 10,434.1 | 3,765.0 | 3,517.7 | 2,720.2 | 2,848.5 | 2,976.5 | 2,602.7 | 2,581.5 | 2,235.4 | 1,912.1 | 2,263.3 | 2,025.4 | 2,587.2 | 2,825.2 | 1,141.0 | -1,780.4 | -20,370.5 |
ADDITIONAL INFOS: | ||||||||||||||||||
Equity Capital | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 | 4,950.6 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 4.3 | 5.6 | 2.7 | 2.5 | 2.1 | 2.3 | 2.1 | 1.9 | 1.9 | 1.6 | 1.5 | 1.5 | 1.4 | 1.9 | 1.8 | 0.9 | -0.3 | -7.5 |
Operating Profit Margin | 39.8 | 35.8 | 41.6 | 43.9 | 34.8 | 35.6 | 36.3 | 38.0 | 33.9 | 30.5 | 42.5 | 36.1 | 43.7 | 37.8 | 40.5 | 35.8 | 18.2 | 29.3 |
Net Profit Margin | 28.8 | 52.8 | 24.7 | 26.1 | 19.1 | 19.6 | 19.9 | 20.0 | 17.9 | 14.4 | 12.3 | 15.3 | 17.8 | 15.1 | 18.3 | 7.1 | -32.5 | -120.2 |
The Industry Net Sales Growth stands at 14.33, vs the Net Sales Growth of -27.29, which results in a Negative aspect.
The Industry Mcap Growth stands at 26.89, vs the Mcap Growth of -13.75, which results in a Negative aspect.
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
24-01-2025 | Quarterly Results |
25-10-2024 | Quarterly Results |
24-01-2024 | Quarterly Results |
30-10-2023 | Quarterly Results |
21-07-2023 | Quarterly Results |
12-05-2023 | Audited Results & Final Dividend |
25-01-2023 | Quarterly Results |
21-10-2022 | Quarterly Results & Inter alia, to consider the Enabling resolution for raising of funds through NCDs and/or other debt securities. |
29-07-2022 | Quarterly Results |
17-05-2022 | Dividend & Audited Results |
31-01-2022 | Quarterly Results |
28-10-2021 | Quarterly Results |
26-07-2021 | Quarterly Results & Dividend |
11-06-2021 | Audited Results |